Work

Immune-related adverse events in advanced NSCLC treated with immunotherapy alone or concurrent chemotherapy and immunotherapy.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.8_suppl.83

Authors: John Melson, Daniel Reed, Bethany J. Horton, Margaret Moore, Jacqueline Theresa Brown, Ryan D. Gentzler, Richard Delmar Hall

Institutions: University of Virginia Health System, University of Virginia, Winship Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2960037160

Cites:

Cited by: 3

Related to: 10